Noom Med Review: Cost, GLP-1 Care and What the Fee Buys

Noom Med, judged on what the fee buys

Noom built its following on a psychology-led weight program years before it prescribed anything. The medical service bolts clinician oversight and GLP-1 prescribing onto that curriculum, so one charge covers lessons, logging and coaching, and a second covers the drug. The entry point is $99 a month, billed quarterly after the first 4-week supply, with semaglutide and tirzepatide both tracked at $179 for a one-month supply. That pairing works well if you want habit coaching and a prescription pathway behind one login, and badly if you want a single flat charge you can drop in any given month. Most Noom Med reviews end up arguing about the billing rhythm rather than the clinical care, so that is the sensible place to start.

The honest summary: a fair entry price, an unusually clean medication price, a behaviour program with real substance, and a billing cycle that punishes indecision. Read the money section twice, then decide.

The money: entry fee, medication cost and the quarterly switch

What the monthly fee actually covers

The published entry price is $99 a month. That figure buys the clinical wrapper and the coaching product: intake review by a licensed prescriber, ongoing clinician messaging, the lesson curriculum, food and weight logging, and the coaching layer inside the app. It does not buy the medication. Cash pricing is published before you complete intake, which is more than several weight-loss telehealth services manage, and it lets you model the full cost against the wider market using our GLP-1 Telehealth Comparison before you hand over a card.

Medication is a separate $179 a month

Semaglutide and tirzepatide are each tracked at $179 for a one-month supply. Those two lines, the program fee and the drug, are billed separately, so treat them as two numbers rather than one. Equal pricing across both molecules is worth more than it looks: when the two drugs cost the same, the choice can be clinical, driven by tolerance, medical history and response, instead of driven by which one is cheaper this quarter.

That $179 figure also sets your expectations about what you are receiving. Brand-name GLP-1 weight-management products carry US list prices well above that level, so ask directly which product, strength and pharmacy sit behind your prescription before your first charge clears.

Quarterly billing is the part people trip over

After the first four-week supply, the charge arrives as a quarter rather than a month. Three practical consequences follow. The bill lands as a lump sum, so the number on your statement will look nothing like the monthly figure that got you interested. Your exit window narrows to a date rather than a month, because cancelling mid-quarter does not automatically shrink a charge already taken. And your true commitment is longer than a month, which matters most in the first twelve weeks, when gut side effects are at their loudest and quitting is most tempting.

If you want the twelve-month picture instead of the monthly one, add the program fee and the medication line together and run the year out:

Cash pay only, so no copay and no deductible credit

The service does not bill insurance. Nothing you pay counts toward a deductible, and no copay logic applies. That is not automatically a bad deal, because coverage for weight-loss drugs is uneven: Medicare Part D has long excluded drugs used only for weight loss, and commercial plans differ sharply on obesity medication, as the Medicare outpatient drug coverage rules set out. If your employer plan does cover a brand GLP-1 with a modest copay, that route usually beats any cash program on price. If it excludes weight-loss drugs outright, a published cash price is the clearer comparison.

Cancelling, and the refund question

Cancellation happens in your account settings, and the date is what matters. Before you enrol, ask support in writing for two things: the exact next renewal date, and whether any part of an unused quarter is refundable. Save the reply. Then set a calendar reminder a week before renewal so a decision you have already made does not turn into another three months of charges.

Quick tip: screenshot the checkout page showing both charges, the program fee and the medication line, before you confirm.

The three tracks side by side

The service is one program with three moving parts. Comparing them on care attributes rather than price makes the trade-offs visible.

The behaviour program: the part Noom is known for

How the curriculum works

The non-medical side is a structured course delivered in short daily lessons, built around food logging, calorie density and the psychology of eating. You log meals, weigh in, read a lesson, and answer prompts. It is not a meal plan, and it does not tell you what to buy. The theory is that changing how you think about food outlasts any single diet.

Why that matters on a GLP-1

Medication and behaviour change are not rivals. Prescribing guidance from the National Institute of Diabetes and Digestive and Kidney Diseases treats weight-loss drugs as an addition to diet and activity changes, not a replacement for them. The trials behind these medicines were run the same way, with lifestyle support alongside the injection. Buying coaching and prescribing together is therefore a defensible design rather than a marketing bundle.

Who gets the most from it

Loggers do well here. If you find daily tracking tolerable, even mildly satisfying, the curriculum gives structure to the appetite drop that a GLP-1 creates. If you have already logged food for years and know your patterns cold, you are paying for a layer you may not use, and a leaner prescribing-only service may serve you better.

The semaglutide track

How semaglutide works

Semaglutide is a GLP-1 receptor agonist, a medicine that mimics an appetite and blood-sugar hormone your gut already makes. It slows stomach emptying and reduces hunger signalling, so most people eat less without white-knuckling it. The FDA approved the weight-management version in 2021 for chronic weight management alongside diet and activity, as the FDA approval announcement describes.

Titration and the schedule

It is a once-weekly injection, and the dose climbs in steps over months rather than starting high. That ladder exists to blunt nausea. Expect check-ins tied to dose increases, and expect the clinician to hold a dose if your gut is struggling. Ask what the intended ladder is, how dose changes are requested, and how quickly a clinician replies when a step goes badly. Our Semaglutide Dosing And Costs notes cover the class detail in more depth.

Side effects worth planning for

Nausea, vomiting, diarrhoea, constipation and reflux are the common complaints, and they cluster around dose increases. Gallbladder problems, pancreatitis and dehydration are less common but more serious, and the drug carries a boxed warning about thyroid C-cell tumors seen in rodents, summarised in the MedlinePlus semaglutide information. People with a personal or family history of medullary thyroid carcinoma or MEN 2 should not take it.

What the evidence shows

In the STEP 1 trial, adults without diabetes taking weekly semaglutide 2.4 mg alongside lifestyle support lost substantially more weight than those on placebo over 68 weeks, reported in the STEP 1 trial publication. Individual results vary widely, and weight tends to return when treatment stops, which is a cost question as much as a clinical one.

Cost inside this program

At $179 a month for a one-month supply, the drug line sits on top of the program fee. If semaglutide is your preference, price the pair together for a year, not for a first month.

The tirzepatide track

Two hormone pathways instead of one

Tirzepatide acts on both GIP and GLP-1 receptors, so it works on two incretin pathways rather than one. The FDA approved the weight-management version in late 2023 for chronic weight management with diet and exercise, per the FDA approval announcement for the dual agonist.

Titration and monitoring

Same rhythm: weekly injection, stepped dose increases, and follow-up focused on tolerance. Blood pressure, heart rate, hydration and any new abdominal pain deserve attention as the dose rises. If you take insulin or a sulfonylurea for diabetes, hypoglycaemia risk rises and those doses may need review by whoever manages your diabetes care.

Side effects and who should avoid it

Gut effects dominate again, and the same class boxed warning about thyroid C-cell tumors applies. Severe or persistent vomiting, signs of dehydration, or sharp upper abdominal pain radiating to the back all warrant contacting a clinician promptly rather than waiting for the next check-in. Our Tirzepatide Side Effects notes go further on what to watch.

What the evidence shows

SURMOUNT-1 tested weekly tirzepatide in adults with obesity or overweight without diabetes and reported large average weight reductions against placebo over 72 weeks, published in the SURMOUNT-1 trial report. Trial conditions include structured support, which is one argument for taking the coaching side of a bundled program seriously.

Choosing between the two

Because both are priced the same here, the decision comes down to history and tolerance: past response, side-effect experience, other conditions, and what your clinician judges safest. Ask which molecule the prescriber would pick for someone with your history, and why. A service that answers that question specifically is doing its job.

Brand, compounded, and what $179 implies

Two questions dominate searches, and both deserve straight answers. Does the service prescribe brand Zepbound? Is its GLP-1 the same as Ozempic? The medication figure here does not match US brand list pricing for weight-management products, so do not assume you are getting a brand pen at that number. Ozempic, meanwhile, is the same molecule as the weight-management semaglutide product but is approved for type 2 diabetes, which is why the two names appear on different labels.

If a plan involves compounded medication, the risk profile shifts. Compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness or quality before sale, and the agency has repeatedly flagged dosing errors and counterfeit products in this space in its semaglutide safety information. Ask three questions before paying: is this an FDA-approved product or a compounded preparation, which licensed pharmacy dispenses it, and how is the strength verified. Our GLP-1 Medication Guides lay out what changes clinically between those answers.

Dose questions to settle before your first charge

• Does the plan follow the label dose ladder, or a lower-dose protocol? Both exist in telehealth, and they behave differently on cost, side effects and expected results.
• What happens if you plateau: a dose increase, a molecule switch, or a coaching change?
• What is the refill trigger, and how many days before you run out should you request one?
• If supply of a strength is disrupted, what is the substitution policy?
• If you stop, what is the taper or exit plan, and does the coaching continue without the drug?

Signing up, step by step

Step 1: check the clinical thresholds before you pay

Weight-management GLP-1 labels are written around a BMI of 30 or more, or 27 or more with a weight-related condition such as high blood pressure or type 2 diabetes. Knowing roughly where you sit avoids paying for an intake that ends in a decline. Work out your figure first:

Step 2: complete the health intake honestly

Expect questions about weight history, medications, pregnancy or breastfeeding, thyroid cancer history, pancreatitis, gallbladder disease, eating disorders and diabetes treatment. Under-reporting here is the single fastest way to make a telehealth prescription unsafe. A prescriber is deciding on the strength of what you type.

Step 3: choose the plan and see both charges

Before you confirm, you should be able to see the program fee and the medication cost as distinct lines, plus the renewal cycle. If any of those three is unclear at checkout, stop and ask support.

Step 4: clinician review

A licensed prescriber reviews your intake. Depending on your state’s telehealth rules, that may be asynchronous or a live visit. Prescription medication through telehealth always requires evaluation by a licensed prescriber, so a service that promised otherwise would be the red flag, not the norm.

Step 5: prescription routing and first delivery

If a prescription is appropriate, it goes to the dispensing pharmacy and ships to you. Ask about shipping method and cold-chain handling, since these medicines need refrigeration until use.

Step 6: onboarding and the first four weeks

Start logging from day one rather than waiting for the drug to arrive. The first month is also your best window to test how responsive clinician messaging is, before the billing cycle changes shape.

Where the service reaches

Telehealth prescribing and medication availability vary state by state, so confirm coverage for your state, and the specific medication, before paying. If you move mid-plan, ask what happens to your prescription.

Living in the app: logging, messaging and signing in

The app is the mature part of this operation, and it shows. Lessons, food and weight logging, coaching and clinician messaging sit in one account rather than being scattered across separate tools, which is a real advantage over services that bolt a chat window onto a checkout.

Sign-in questions are common enough to be worth stating plainly: use the same email or sign-in method you created the account with, since a second account will not carry your plan. Billing, plan changes and cancellation live in account or subscription settings, not in the coaching feed, so look there rather than asking a coach to cancel for you. If a browser session and the app disagree about your plan status, treat the account settings view as the record and screenshot it.

Quick tip: turn on notifications only for clinician replies and refill alerts. Coaching nudges are easy to mute into irrelevance.

Support, refills and escalation

Support runs through in-app messaging and the coaching relationship. No published response-time commitment or refill turnaround figure accompanies the plan, so treat responsiveness as something to test rather than assume. In the first month, send one non-urgent clinical question and note how long the reply takes. That single data point tells you more than any marketing page.

Refill timing is the practical risk on a weekly injection. A gap between shipments means a missed dose, and missed doses on a titration schedule sometimes mean stepping back down. Ask how many days ahead refills are processed, whether shipping delays trigger a proactive message, and who you contact when a package is late. Escalation matters too: find out now how an urgent side-effect concern reaches a clinician rather than a coach, and what the service tells you to do outside working hours. For anything acute, urgent care or emergency services remain the answer, not an app inbox.

Privacy and what to check before you upload your health history

You are handing over weight, medication and medical history data to a company that also runs a consumer wellness app, and those two roles can sit under different privacy rules. Clinical records created by a licensed prescriber generally fall under HIPAA protections; data you type into a consumer app for coaching or marketing purposes may not carry the same protection.

Four things worth reading in the privacy policy before intake: what health data is collected beyond the clinical record, whether any of it is shared with advertising or analytics partners, whether the clinical side is described as covered by HIPAA, and how to request deletion of your account data if you leave. If you use a connected scale or tracker, check what that integration shares as well. Ask support directly for the deletion process in writing; a service that answers cleanly is telling you something useful about its data hygiene.

Is Noom Med legit? What the record shows

Yes, on the signals that can actually be checked. The service is LegitScript certified, a review of telehealth and pharmacy operators that examines licensing and compliance and can be looked up through the LegitScript certification program. Prescribing is done by licensed clinicians, cash pricing is published before intake rather than revealed after a consult, and the product is a long-established consumer health brand rather than an anonymous storefront.

The complaints that show up in public discussion are commercial, not clinical: confusion about what the charge becomes after the first four-week supply, difficulty timing a cancellation, and disagreement about what the medication actually is. Those are real irritations, and this review names them plainly, but they are billing-design problems rather than evidence of an illegitimate operation. Our prices are desk-verified against the provider’s live site and re-checked monthly, and you can see How We Score Providers if you want the weighting behind that judgement.

Staying safe on a GLP-1: warnings, monitoring and when to call

These are effective medicines with a real risk profile, and the class labels are specific about it. Both molecules carry a boxed warning about thyroid C-cell tumors observed in rodents, and both are contraindicated in people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Neither is for use in pregnancy, and anyone who could become pregnant should discuss contraception and planning before starting.

Common effects include nausea, vomiting, diarrhoea, constipation, reflux and fatigue, usually worst after a dose step. Serious problems to act on rather than wait out include severe or persistent vomiting, signs of dehydration such as very dark urine or dizziness, sharp abdominal pain that spreads to the back, yellowing of the eyes or skin, and vision changes in people with diabetic retinopathy. Report any history of pancreatitis, gallbladder disease, severe gastrointestinal disease or gastroparesis at intake, since these change the calculation. General condition background sits in the MedlinePlus obesity overview.

Monitoring is where a program earns its fee. Weight, blood pressure, hydration, side-effect severity and, where relevant, blood sugar all deserve tracking. If you take insulin or a sulfonylurea, hypoglycaemia risk increases and doses may need adjusting by the clinician who manages that treatment. Anyone with kidney disease, a history of eating disorders, or planned surgery involving anaesthesia should raise it before the first injection, not after.

Who this program suits, and who should look elsewhere

A good match if:

• You want behaviour coaching and prescribing in one account, not two subscriptions.
• You log food willingly, or want a structure that pushes you to.
• Your insurance excludes weight-loss drugs, so a published cash price is your real comparison.
• You are comfortable committing for a quarter at a time once the first supply ends.
• You want the same price whichever of the two molecules the clinician recommends.

Look elsewhere if:

• You need month-to-month flexibility with an exit at any point.
• You have plan coverage for a brand GLP-1 with a workable copay.
• You already have coaching, a dietitian or a habit system that works, and want prescribing only.
• You want a guaranteed FDA-approved brand product and are not prepared to accept an alternative.
• You want in-person examination and lab work handled under one roof.

If flexibility is the deciding factor, scan the Weight Loss Telehealth Directory for services that bill monthly and compare the annual totals rather than the headline figures.

Questions to ask before you enrol, and what to ask your current provider

Ask this service: which exact medication and strength will be dispensed, and by which pharmacy; whether it is FDA-approved or compounded; what the dose ladder is and who approves each step; the exact next billing date and refund terms; how urgent side-effect messages are routed; and how records are provided if you leave.

If you are switching from another program, ask that one for a copy of your clinical records and dose history, when your current supply and prescription end, and the last date you can cancel without another charge. Overlapping two subscriptions for a month is the most common avoidable cost in this category. Price both routes side by side before you move, using Run My Numbers, and see what a full write-up looks like in our Sample Provider Report.

Reputation check

Public sentiment about this brand concentrates in three attributable places: its Better Business Bureau profile, its Apple App Store listing, and its Google Play listing. Read them for different things. The BBB profile is the better guide to how billing disputes, cancellation requests and refund arguments get handled, which is exactly where the recurring criticism of this service sits. The app-store listings are the better guide to daily experience, covering logging, lesson quality, sign-in problems and how responsive coaching feels once the novelty fades.

Across public discussion forums, the themes in Noom Med reviews repeat with unusual consistency: what the program costs without insurance, how the charge changes after the first supply, how to cancel cleanly, and whether the medication is the same thing as the brand names people recognise. Clinical complaints appear far less often than commercial ones. None of that constitutes a clinical verdict, and the moderated member reviews shown on this page are separate from those external listings. Where a specific number matters to you, read the source listing itself rather than a summary of it.

Educational content, not medical advice. Always consult a qualified clinician before starting, stopping or switching treatment.